Clinical Trial Update: Schedules of Nab-Paclitaxel in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating schedules of nab-paclitaxel in metastatic breast cancer completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: ETOP IBCSG Partners Foundation | Conditions: Metastatic Breastcancer | Phase 2 | Status: COMPLETED | Results posted: 2020-03-27